Nuvectis Pharma (NVCT) Stock Chart & Stock Price History $8.17 -0.11 (-1.33%) Closing price 04:00 PM EasternExtended Trading$8.20 +0.03 (+0.37%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nuvectis Pharma Stock Price Performance The Nuvectis Pharma (NVCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 18.41%, with a year-to-date return of 51.02%. In the past month, the stock has decreased 5.44%, reflecting recent market activity. As of the latest close, Nuvectis Pharma traded at $8.28 with a market cap of $173.00 million and volume of 112,992 shares. Receive NVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.68%1 Month Performance-5.44%3 Month Performance-6.09%Year-To-Date Performance+51.02%1 Year Performance+18.41% NVCT Stock Chart for Wednesday, July, 16, 2025 NVCT Chart by TradingView Nuvectis Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$8.22$8.28+0.73%$8.50$8.11112,992 shs$173.00 million07/14/2025$7.88$8.22+4.31%$8.57$7.76201,162 shs$171.75 million07/11/2025$8.19$7.88-3.79%$8.19$7.8544,034 shs$164.65 million07/10/2025$8.08$8.19+1.36%$8.30$7.8945,513 shs$171.09 million07/09/2025$7.58$8.08+6.60%$8.10$7.5662,573 shs$168.79 million07/08/2025$7.85$7.58-3.44%$8.05$7.5786,173 shs$158.35 million07/07/2025$7.70$7.85+1.95%$7.98$7.47126,589 shs$163.99 million07/04/2025$7.70$7.70$7.59$7.4636,289 shs$160.88 million07/03/2025$7.52$7.70+2.39%$7.59$7.4636,289 shs$160.85 million07/02/2025$7.31$7.52+2.87%$7.59$7.3272,170 shs$157.09 million Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$7.47$7.31-2.14%$7.57$7.25122,273 shs$152.71 million06/30/2025$7.55$7.47-1.06%$7.83$7.37146,873 shs$156.05 million06/27/2025$7.71$7.55-2.08%$7.87$7.421.87 million shs$157.72 million06/26/2025$7.74$7.71-0.39%$8.06$7.70166,813 shs$161.06 million06/25/2025$7.98$7.74-3.01%$8.27$7.7281,128 shs$161.72 million06/24/2025$7.96$7.98+0.25%$8.18$7.9071,667 shs$166.70 million06/23/2025$8.13$7.96-2.09%$8.27$7.84116,327 shs$166.28 million06/20/2025$8.05$8.13+0.99%$8.20$7.9093,851 shs$169.87 million06/19/2025$8.05$8.05$8.33$7.91103,552 shs$168.16 million06/18/2025$8.11$8.05-0.74%$8.33$7.91103,552 shs$168.16 million06/17/2025$8.64$8.11-6.13%$8.86$8.1184,913 shs$169.45 million06/16/2025$8.41$8.64+2.73%$8.89$8.3679,296 shs$180.52 million Related Companies MRVI Stock Price Chart IOVA Stock Price Chart URGN Stock Price Chart TLRY Stock Price Chart TNGX Stock Price Chart STOK Stock Price Chart PRME Stock Price Chart DNTH Stock Price Chart PHAT Stock Price Chart UPB Stock Price Chart Receive NVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NVCT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVCT Stock Alerts